ERYTECH PHARMA - SPONSORED ADR (PHXM)

CUSIP: 29604W108

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / SPONSORED ADR
Total 13F shares
741,962
Share change
-743,120
Total reported value
$244,803
Price per share
$0.33
Number of holders
8
Value change
-$503,703
Number of buys
3
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 29604W108?
CUSIP 29604W108 identifies PHXM - ERYTECH PHARMA - SPONSORED ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ERYTECH PHARMA - SPONSORED ADR (PHXM) as of Q4 2022

As of 31 Dec 2022, ERYTECH PHARMA - SPONSORED ADR (PHXM) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 741,962 shares. The largest 8 holders included Jefferies Financial Group Inc., Vanguard Personalized Indexing Management, LLC, Mariner, LLC, CITADEL ADVISORS LLC, GROUP ONE TRADING, L.P., UBS Group AG, Asset Dedication, LLC, and Ikarian Capital, LLC. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.